Developer docs
API playgroundTry for free, no card

Search company profiles

Helpharma

Full company profile

uuid000pc2e

Namestring
Helpharma
Legal namestring
Helpharma
Websiteurl
helpharma.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Helpharma is a privately held Colombian healthcare services company operating as an IPS (Institución Prestadora de Servicios de Salud), founded around 2011 and headquartered in Medellín. The company provides integrated pharmaceutical and clinical services for chronic disease patients across Colombia through a network of 24 locations — including 6 IPS facilities with dispensary and medication application rooms and 17 owned pharmacies — spanning Medellín, Bogotá, Barranquilla, Manizales, Cali, Rionegro, Pereira, and Armenia. Its operations are organized around four core service lines: Gestor Farmacéutico (pharmaceutical dispensing and clinical risk management), Servicio de Aplicación Monitorizada (monitored administration of biological and specialized therapies), Medicamentos a Domicilio (home medication delivery with online tracking), and Programas de Atención Integral (multidisciplinary chronic disease care programs covering immunoarthropathies, respiratory diseases, immunological disorders, osteoporosis, orphan diseases, cancer adjuvant therapies, and RSV prophylaxis).

The business is structured around partnerships with Colombian health insurance companies (EPS), with SURA EPS and Compensar EPS named as core channel partners. Each EPS integration is operationally deep: Helpharma runs dedicated patient portals for home delivery (medicamentos.helpharma.com for SURA, intranet.helpharma.com for Compensar) and an integrated appointment scheduling system supporting 50+ medication types. The combined scale is approximately 100,000-115,000 monthly dispensations and 8,000 monthly medication applications (70% in-facility, 30% home-based), with reported operational metrics including a 97% global service experience rating, sub-10-minute wait times at dispensing facilities, and sub-48-hour application scheduling. The company holds ISO 13485 certification for medical device quality management.

Helpharma's underlying technology stack consists of a TuViCare/Zentria-branded patient portal, a centralized intranet appointment scheduling system, dedicated EPS delivery portals, call-center infrastructure, and WhatsApp business channels segmented by therapy type. Patient engagement runs through the +helPharma website, a call center, WhatsApp, and the blog NotiHelPharma. The company is sales-led, employing 501-1,000 staff across Colombia, operates without disclosed external funding, and is independently held with no parent company or institutional investors identified in source material.

Short descriptiontext

Helpharma is a Colombian private healthcare services company operating as an IPS, providing integrated pharmaceutical dispensing, monitored medication administration, home delivery, and multidisciplinary chronic-disease care programs across 24 locations, serving patients primarily through partnerships with SURA EPS and Compensar EPS.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMedellín, Colombia
HQ citystring
Medellín
HQ countrystring
Colombia
HQ regionstring
Latin America
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical management services, monitored medication application, chronic disease care programs, home medication delivery, biological therapy administration
NAICS code2 codes
  • Social Assistance624
  • Other Individual and Family Services62419
SIC code2 codes
  • Services-Health Services8000
  • Services-Misc Health & Allied Services, Nec8090
Product category
Specialty Pharmaceutical Services (IPS)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Pharmaceutical Dispensing Services
TypeSubscription Recurring
Description

Dispensación oportuna de medicamentos y acompañamiento de los pacientes para mejorar adherencia, identificar y gestionar riesgos farmacológicos y clínicos. Approximately 100,000-115,000 monthly dispensations with 45% home delivery rate.

helpharma.com
2Monitored Medication Application Services
TypeSubscription Recurring
Description

Application of biological therapies and specialized medications both at facilities and at home. Approximately 8,000 applications per month with 70% in-facility and 30% home-based.

helpharma.com
3Comprehensive Health Programs
TypeSubscription Recurring
Description

Integral multidisciplinary care programs for chronic diseases including immunoarthropathies, respiratory diseases, and immunological disorders.

helpharma.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Helpharma is a Colombian healthcare services provider (IPS) that delivers integrated pharmaceutical and clinical management for chronic disease patients. Its core offerings combine medication dispensing under the Gestor Farmacéutico program, monitored application of biological and specialized therapies, home delivery of medications, and multidisciplinary comprehensive care programs for immunoarthropathies, respiratory, and immunological disorders, contracted primarily through Colombian health insurance partners (EPS).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 97% global service experience rating
+5 more records
Product overview1 text field

Helpharma is a pharmaceutical and medical services company operating as an integrated platform with four interconnected core services: Gestor Farmacéutico (pharmaceutical dispensing and clinical risk management with 100,000+ monthly dispensations), Servicio de Aplicación Monitorizada (monitored medication administration with ~8,000 monthly applications at facilities or homes), Medicamentos a Domicilio (home delivery), and Programas de Atención Integral (multidisciplinary chronic disease programs). The +helPharma ecosystem is supported by a Patient Portal (TuViCare/Zentria) and an online Appointment Scheduling System. The company operates 24 national locations including 6 IPS facilities with dispensing and application services plus 17 pharmacies, serving EPS patients primarily through SURA and Compensar.

Product and service6 records
1Gestor Farmacéutico (Pharmaceutical Manager)
CategorySpecialty pharmaceutical dispensing and clinical risk management
Description

Pharmaceutical management service focused on timely medication dispensing and patient accompaniment to improve treatment adherence, and to identify and manage pharmacological and clinical risks for high-cost chronic disease patients; processes approximately 100,000–115,000 monthly dispensations.

2Servicio de Aplicación Monitorizada de Medicamentos (Monitored Medication Application Service)
CategoryMonitored medication administration / home and ambulatory infusion
Description

Ambulatory medication injection service provided by trained health personnel at Helpharma facilities and at patients' homes, performing approximately 8,000 monthly applications (around 70% in-facility and 30% home-based); covers biological therapies, immunoglobulins, and other specialized high-cost treatments for chronic disease patients.

3Medicamentos a Domicilio (Home Medication Delivery)
CategorySpecialty medication home delivery
Description

Home delivery service for prescribed medications enabling patients to receive prescriptions at their preferred location, eliminating pharmacy visits and offering online tracking of order status; integrated with EPS partner portals such as medicamentos.helpharma.com (SURA EPS) and intranet.helpharma.com/domicilios/compensar (Compensar EPS).

4Programas de Atención Integral en Salud (Comprehensive Health Attention Programs)
CategoryComprehensive multidisciplinary chronic disease programs
Description

Comprehensive multidisciplinary care programs for chronic disease patients covering immunoarthropathies and skin diseases, respiratory conditions (asthma, COPD), immunological disorders, and allergology; uses integrated clinical-pharmaceutical management with demonstrated success rates greater than 92% in immunomediated conditions.

5Portal del Paciente (Patient Portal – TuViCare/Zentria)
CategoryPatient self-service platform
Description

Online patient portal (TuViCare/Zentria) that allows patients to check the status of pending medication, manage application appointments, and access health records related to their Helpharma-prescribed therapies.

6Sistema de Citas de Aplicación (Application Appointment System)
CategoryAppointment scheduling platform
Description

Web-based self-service scheduling system for medication application appointments, integrated with SURA EPS and Compensar EPS systems and supporting 50+ medication types; accepts submissions from patients and caregivers for biological therapies and other specialized treatments.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

SURA EPS is a major Colombian health insurance company (EPS) that partners with Helpharma for medication dispensing and home delivery services. Helpharma provides medication home delivery services specifically for SURA EPS patients through a dedicated portal.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of Colombia's largest retail pharmacy chains, with broad dispensing and home-delivery capabilities; comparable in retail-pharmacy scale and EPS-contracted dispensing operations.

2Mckenzie Colombia
TypeDirect peer
Description

Specialty pharmaceutical distributor in Colombia focused on high-cost and orphan therapies; comparable in handling complex biologics and serving chronic-disease patients.

3Farmatodo
TypeDirect peer
Description

Major Colombian pharmacy chain with home-delivery, digital channels, and growing specialty services; competes directly with Helpharma on dispensing convenience and chronic-disease patient reach.

4EPS Sanitas
TypeBroad incumbent
Description

Colombian health insurance (EPS) operator with vertically integrated provider networks; comparable as both potential channel partner and competitor to Helpharma's payer-aligned service model.

5BioRx
TypeEmerging player
Description

US specialty infusion and high-touch pharmaceutical services provider; comparable as a business-model analog for monitored specialty medication administration at home and at facilities.

6Inkafarma
TypeRegional player
Description

Peruvian pharmacy chain with national footprint, home delivery, and chronic-disease offerings; comparable as a Latin American specialty/retail pharmacy operator, useful for cross-border benchmarking.

7Droguerías Colsubsidio
TypeDirect peer
Description

Affiliated pharmacy network serving a major Colombian caja compensadora; offers dispensing and patient services to a defined population, comparable to Helpharma's payer-channeled model.

TypeRegional player
Description

Colombian ambulatory IPS focused on specialty home-based care and chronic-disease management, conceptually similar to Helpharma's monitored medication application and integral care programs.

9Salud Total EPS
TypeBroad incumbent
Description

Colombian EPS that contracts with provider networks including pharmacy and IPS services; comparable as a payer-side counterparty in Helpharma's distribution channel ecosystem.

TypeDirect peer
Description

Colombian specialty pharmacy and chronic-disease patient management provider operating IPS infrastructure and home-delivery dispensing, directly comparable to Helpharma's Gestor Farmacéutico and monitored application model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Helpharma

Specialty Pharmaceutical Services (IPS)helpharma.com

Helpharma is a Colombian private healthcare services company operating as an IPS, providing integrated pharmaceutical dispensing, monitored medication administration, home delivery, and multidisciplinary chronic-disease care programs across 24 locations, serving patients primarily through partnerships with SURA EPS and Compensar EPS.

What Helpharma does

Helpharma is a privately held Colombian healthcare services company operating as an IPS (Institución Prestadora de Servicios de Salud), founded around 2011 and headquartered in Medellín. The company provides integrated pharmaceutical and clinical services for chronic disease patients across Colombia through a network of 24 locations — including 6 IPS facilities with dispensary and medication application rooms and 17 owned pharmacies — spanning Medellín, Bogotá, Barranquilla, Manizales, Cali, Rionegro, Pereira, and Armenia. Its operations are organized around four core service lines: Gestor Farmacéutico (pharmaceutical dispensing and clinical risk management), Servicio de Aplicación Monitorizada (monitored administration of biological and specialized therapies), Medicamentos a Domicilio (home medication delivery with online tracking), and Programas de Atención Integral (multidisciplinary chronic disease care programs covering immunoarthropathies, respiratory diseases, immunological disorders, osteoporosis, orphan diseases, cancer adjuvant therapies, and RSV prophylaxis).

The business is structured around partnerships with Colombian health insurance companies (EPS), with SURA EPS and Compensar EPS named as core channel partners. Each EPS integration is operationally deep: Helpharma runs dedicated patient portals for home delivery (medicamentos.helpharma.com for SURA, intranet.helpharma.com for Compensar) and an integrated appointment scheduling system supporting 50+ medication types. The combined scale is approximately 100,000-115,000 monthly dispensations and 8,000 monthly medication applications (70% in-facility, 30% home-based), with reported operational metrics including a 97% global service experience rating, sub-10-minute wait times at dispensing facilities, and sub-48-hour application scheduling. The company holds ISO 13485 certification for medical device quality management.

Helpharma's underlying technology stack consists of a TuViCare/Zentria-branded patient portal, a centralized intranet appointment scheduling system, dedicated EPS delivery portals, call-center infrastructure, and WhatsApp business channels segmented by therapy type. Patient engagement runs through the +helPharma website, a call center, WhatsApp, and the blog NotiHelPharma. The company is sales-led, employing 501-1,000 staff across Colombia, operates without disclosed external funding, and is independently held with no parent company or institutional investors identified in source material.

Helpharma firmographics

Firmographics
Name
Helpharma
Legal name
Helpharma
Website
https://helpharma.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
101–250 employees
Short description
Helpharma is a Colombian private healthcare services company operating as an IPS, providing integrated pharmaceutical dispensing, monitored medication administration, home delivery, and multidisciplinary chronic-disease care programs across 24 locations, serving patients primarily through partnerships with SURA EPS and Compensar EPS.
Ownership category
akta.pro rank

Where Helpharma is headquartered

Location

Headquarters

HQ city
Medellín
HQ country
Colombia
HQ region
Latin America

Offices8 records

Markets served

Helpharma business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Pharmaceutical Dispensing Services: Dispensación oportuna de medicamentos y acompañamiento de los pacientes para mejorar adherencia, identificar y gestionar riesgos farmacológicos y clínicos. Approximately 100,000-115,000 monthly dispensations with 45% home delivery rate.
  2. Monitored Medication Application Services: Application of biological therapies and specialized medications both at facilities and at home. Approximately 8,000 applications per month with 70% in-facility and 30% home-based.
  3. Comprehensive Health Programs: Integral multidisciplinary care programs for chronic diseases including immunoarthropathies, respiratory diseases, and immunological disorders.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Helpharma product offering

Product offering

Core offering

Helpharma is a Colombian healthcare services provider (IPS) that delivers integrated pharmaceutical and clinical management for chronic disease patients. Its core offerings combine medication dispensing under the Gestor Farmacéutico program, monitored application of biological and specialized therapies, home delivery of medications, and multidisciplinary comprehensive care programs for immunoarthropathies, respiratory, and immunological disorders, contracted primarily through Colombian health insurance partners (EPS).

Product overview

Helpharma is a pharmaceutical and medical services company operating as an integrated platform with four interconnected core services: Gestor Farmacéutico (pharmaceutical dispensing and clinical risk management with 100,000+ monthly dispensations), Servicio de Aplicación Monitorizada (monitored medication administration with ~8,000 monthly applications at facilities or homes), Medicamentos a Domicilio (home delivery), and Programas de Atención Integral (multidisciplinary chronic disease programs). The +helPharma ecosystem is supported by a Patient Portal (TuViCare/Zentria) and an online Appointment Scheduling System. The company operates 24 national locations including 6 IPS facilities with dispensing and application services plus 17 pharmacies, serving EPS patients primarily through SURA and Compensar.

Differentiator

Problem solved

Functional benefit

Products and services

  • Gestor Farmacéutico (Pharmaceutical Manager) Pharmaceutical management service focused on timely medication dispensing and patient accompaniment to improve treatment adherence, and to identify and manage pharmacological and clinical risks for high-cost chronic disease patients; processes approximately 100,000–115,000 monthly dispensations.
  • Servicio de Aplicación Monitorizada de Medicamentos (Monitored Medication Application Service) Ambulatory medication injection service provided by trained health personnel at Helpharma facilities and at patients' homes, performing approximately 8,000 monthly applications (around 70% in-facility and 30% home-based); covers biological therapies, immunoglobulins, and other specialized high-cost treatments for chronic disease patients.
  • Medicamentos a Domicilio (Home Medication Delivery) Home delivery service for prescribed medications enabling patients to receive prescriptions at their preferred location, eliminating pharmacy visits and offering online tracking of order status; integrated with EPS partner portals such as medicamentos.helpharma.com (SURA EPS) and intranet.helpharma.com/domicilios/compensar (Compensar EPS).
  • Programas de Atención Integral en Salud (Comprehensive Health Attention Programs) Comprehensive multidisciplinary care programs for chronic disease patients covering immunoarthropathies and skin diseases, respiratory conditions (asthma, COPD), immunological disorders, and allergology; uses integrated clinical-pharmaceutical management with demonstrated success rates greater than 92% in immunomediated conditions.
  • Portal del Paciente (Patient Portal – TuViCare/Zentria) Online patient portal (TuViCare/Zentria) that allows patients to check the status of pending medication, manage application appointments, and access health records related to their Helpharma-prescribed therapies.
  • Sistema de Citas de Aplicación (Application Appointment System) Web-based self-service scheduling system for medication application appointments, integrated with SURA EPS and Compensar EPS systems and supporting 50+ medication types; accepts submissions from patients and caregivers for biological therapies and other specialized treatments.

Quantifiable outcome

  • 97% global service experience rating
  • +5 more outcomes

Companies that use Helpharma

Customer profile

Named customers2 records

Segments1 record

Ideal customer profiles2 records

Helpharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Helpharma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • SURA EPScoreChannel Partner/ Reseller/ DistributorSURA EPS is a major Colombian health insurance company (EPS) that partners with Helpharma for medication dispensing and home delivery services. Helpharma provides medication home delivery services specifically for SURA EPS patients through a dedicated portal.

Scale indicators11 records

Recent moves6 records

Expansion highlights5 records

Helpharma competitors and assessment

Company assessment

Direct peers

  • Cruz Verde: One of Colombia's largest retail pharmacy chains, with broad dispensing and home-delivery capabilities; comparable in retail-pharmacy scale and EPS-contracted dispensing operations.
  • Mckenzie Colombia: Specialty pharmaceutical distributor in Colombia focused on high-cost and orphan therapies; comparable in handling complex biologics and serving chronic-disease patients.
  • Farmatodo: Major Colombian pharmacy chain with home-delivery, digital channels, and growing specialty services; competes directly with Helpharma on dispensing convenience and chronic-disease patient reach.
  • Droguerías Colsubsidio: Affiliated pharmacy network serving a major Colombian caja compensadora; offers dispensing and patient services to a defined population, comparable to Helpharma's payer-channeled model.
  • Audifarma: Colombian specialty pharmacy and chronic-disease patient management provider operating IPS infrastructure and home-delivery dispensing, directly comparable to Helpharma's Gestor Farmacéutico and monitored application model.

Broad incumbents

  • EPS Sanitas: Colombian health insurance (EPS) operator with vertically integrated provider networks; comparable as both potential channel partner and competitor to Helpharma's payer-aligned service model.
  • Salud Total EPS: Colombian EPS that contracts with provider networks including pharmacy and IPS services; comparable as a payer-side counterparty in Helpharma's distribution channel ecosystem.

Emerging players

  • BioRx: US specialty infusion and high-touch pharmaceutical services provider; comparable as a business-model analog for monitored specialty medication administration at home and at facilities.

Regional players

  • Inkafarma: Peruvian pharmacy chain with national footprint, home delivery, and chronic-disease offerings; comparable as a Latin American specialty/retail pharmacy operator, useful for cross-border benchmarking.
  • Promedios IPS: Colombian ambulatory IPS focused on specialty home-based care and chronic-disease management, conceptually similar to Helpharma's monitored medication application and integral care programs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Helpharma social profiles

Digital presence

Helpharma compliance and trust

Trust signal

Compliance1 record

Helpharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Helpharma leadership team

Management profile

Number of profiles

Helpharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Helpharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Helpharma

What does Helpharma do?

Helpharma is a Colombian healthcare services provider (IPS) that delivers integrated pharmaceutical and clinical management for chronic disease patients. Its core offerings combine medication dispensing under the Gestor Farmacéutico program, monitored application of biological and specialized therapies, home delivery of medications, and multidisciplinary comprehensive care programs for immunoarthropathies, respiratory, and immunological disorders, contracted primarily through Colombian health insurance partners (EPS).

Is Helpharma a public or private company?

Helpharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Helpharma founded?

Helpharma was founded in 2011. It employs 101 to 250 people.

Where is Helpharma based?

Helpharma is headquartered in Medellín, Colombia, in the Latin America region.

How does Helpharma make money?

Three revenue lines are on record. Pharmaceutical Dispensing Services are the primary driver. The others are monitored Medication Application Services and comprehensive Health Programs.

Who are Helpharma's main competitors?

Direct peers on record are Cruz Verde, Mckenzie Colombia, Farmatodo, Droguerías Colsubsidio and Audifarma. Broad incumbents are EPS Sanitas and Salud Total EPS. BioRx is listed as an emerging player. Regional players are Inkafarma and Promedios IPS.

Does Helpharma have an API?

No public API is recorded for Helpharma.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales